Newsroom
Publication: Extension of Indication for Authorised Oncology Products in the European Union
A journal article on the topic of "Extension of Indication for Authorised Oncology Products in the European Union" was published last week in the Regulatory Science magazine frontiers in Medicine.
The article was driven by the discussion and questions identified during the RSNN Expert Meeting on Label Modification Based on Evidence Deriving From Investigator-Initiated Trials.
Click here to read the full article